RT Conference Proceedings
T1 Health-related quality of life (HRQoL) at final analysis of the GALAHAD study of niraparib in patients with metastatic castration-resistant prostate cancer (mCRPC) and DNA repair defects (DRD)
A1 Smith, M. R.
A1 Sandhu, S. K.
A1 George, D. J.
A1 Chi, K. N.
A1 Saad, F.
A1 Thiery-Vuillemin, A.
A1 Stahl, O.
A1 Olmos, D.
A1 Danila, D.
A1 Gafanov, R.
A1 Castro, E.
A1 Moon, H.
A1 Joshua, A. M.
A1 Mason, G. E.
A1 Espina, B. M.
A1 Liu, Y.
A1 Bevans, K. B.
A1 Lopez-Gitlitz, A.
A1 Francis, P.
A1 Fizazi, K.
PB Elsevier
SN 0923-7534
YR 2021
FD 2021-09-21
LK https://hdl.handle.net/10668/27059
UL https://hdl.handle.net/10668/27059
LA en
DS RISalud
RD Apr 10, 2025